Naturhouse Health SA · BME:NTH

Naturhouse Health SA — FY2021 Earnings Presentation

13 slides from Naturhouse Health SA's earnings presentation, February 2022

  1. Slide 1: 2021 Results

    2021 Results February 28th 2021

  2. Slide 2: Disclaimer

    Disclaimer This document has been prepared by NATURHOUSE HEALTH S.A. (“NATURHOUSE” or the “Company”) for its exclusive use during the presentations announcing the Company’s results of 4Q20. NATURHOUSE does not authorise its dissemination, publication or use by any other person, whether physical or l

  3. Slide 3: Index

    Index ❑ Main Figures ❑ Consolidated Profit & Loss Account ❑ Quarterly Evolution ❑ Sales and EBITDA by Country ❑ Naturhouse Centres ❑ Net Cash & Dividends ❑ Consolidated Balance Sheet ❑ Strategy & Outlook ❑ Price Sensitive Information Notes for the Period 3

  4. Slide 4: Main Figures

    Main Figures The Board of Directors has proposed the final 2021 dividend payment of 0,2€/share to be paid March 21 st , 2022 leading for a total dividend of 12 million euros Naturhouse has managed to increase its net profit by 4 millions euros compared to 2020, returning to Pre- Pandemic levels. 202

  5. Slide 5: Consolidated Profit & Loss Account

    Consolidated Profit & Loss Account 2021 2020 Variation ❑ Consolidation of growth in sales compared to the previous period (+4.6%) Total Sales 57.594 55.081 2.513 Procurements -16.335 -15.876 -459 ❑ Significant reduction of the operating Gross profit 41.259 39.206 2.053 and general costs Gross profit

  6. Slide 6: Quarterly Evolution

    Quarterly Evolution SALES EBITDA Sep.21 sep.20 var % Sep.21 sep.20 var % Francia 15.245 16.162 -5,7% Francia 6.761 6.860 -1,4% España 9.099 8.592 5,9% España 3.310 2.764 19,8% Italia 13.172 11.188 17,7% Italia 5.258 3.417 53,9% Polonia 5.603 5.717 -2,0% Polonia 1.979 1.213 63,1% Resto 1.428 1.420 0,

  7. Slide 7: Sales & EBITDA by Country

    Sales & EBITDA by Country Sales according to country Sales breakdown by country 2021 2020 % ❑. Turnover at the end of 4Q20 stands at 57.6 million euros. France 20.156 20.661 -2,4% ✓ The Company has managed to maintain a positive level of sales compared to the previous year, growing Spain 11.885 11.1

  8. Slide 8: Naturhouse Centres

    Naturhouse Centres 1,682 centres in 31 countries -102 net closes in Q4 2020 as part of the company’s business optimisation plan to improve the average revenue per store +156 +81 -77 -95 -400 -102 Net openings: -99 franchises mainly due to the company’s business optimisation plan in the markets with

  9. Slide 9: Net Cash Position & Dividends

    Net Cash Position & Dividends Naturhouse continues to maintain an excellent level of cash, which allows it to enjoy great economic and financial strength (1) (*) (*) Figures in thousands of euros Figures in thousands of euros (*) This does not include the €2,2m pending repayment by the Spanish Tax A

  10. Slide 10: Balance Sheet

    Balance Sheet 2021 2020 Intangible assets 753 972 Property, plant & equipment 2.674 3.998 Non current financial assets 1.399 696 ❑ Accoriding to the policy of closing its own Investment in associated companies 6.793 3.276 centers to optimize operating costs, it causes Deferred tax assets 107 197 pro

  11. Slide 11: Strategy and Outlook

    Strategy and Outlook Our main objective is to continue creating value for our shareholders and remain at the forefront of the Spanish Stock Exchange in terms of dividend policy Strategy ✓ After the experience in the development of the digital business in the English and North American markets, the c

  12. Slide 12: Material Facts for the period

    Material Facts for the period Material facts for the period ❑ March 1, 2021: Annual Corporate Governance Report ❑ March 1, 2021: Board Members’ Compensation Report ❑ March 1, 2021: Corporate Social Responsibility Report ❑ March 1, 2021: 2019 Results ❑ May 14, 2021: General Shareholder’s Meeting Call

  13. Slide 13: Contact

    CONTACT Manuel Castro CFO Tel: +34 914323953 Email: [email protected] 13

Naturhouse Health — FY2021 Earnings Presentation on 6ix